Related Experiment Videos
CCR5 and HIV infection.
Cédric Blanpain1, Frédérick Libert, Gilbert Vassart
1IRIBHN, Université Libre de Bruxelles, Brussels, Belgium.
Receptors & Channels
|October 31, 2002
Summary
Chemokine receptor CCR5 is vital for HIV-1 transmission and AIDS progression. Genetic variations like CCR5 delta 32 influence infection resistance and disease outcome, making CCR5 a key therapeutic target.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Chemokines and their receptors mediate leukocyte trafficking and are implicated in various diseases.
- CCR5 is a critical coreceptor for M-tropic HIV-1 and HIV-2 strains, playing a key role in viral transmission and pathogenesis.
Purpose of the Study:
- To explore the role of CCR5 in HIV pathogenesis and its potential as a therapeutic target.
- To investigate the impact of CCR5 genetic variations on HIV infection and AIDS progression.
Main Methods:
- Analysis of CCR5 expression patterns and its signaling pathways.
- Examination of the CCR5 delta 32 allele and other genetic variants in relation to HIV resistance and AIDS progression.
Main Results:
- CCR5 agonists (MIP-1 alpha, RANTES) and antagonists (MCP-3) modulate receptor activity.
- The CCR5 delta 32 allele confers resistance to HIV infection, with homozygotes showing strong resistance and heterozygotes delayed AIDS progression.
Conclusions:
- CCR5 is a significant drug target for HIV and inflammatory diseases.
- Genetic variations in CCR5 influence HIV susceptibility and disease course, offering insights for therapeutic strategies.